You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.


Implementing the NASH Clinical Care Pathway

  • Authors: Kenneth Cusi, MD; Fasiha Kanwal, MD, MSHS, AGAF, FAASLD
  • CME Released: 12/28/2022
  • Valid for credit through: 12/28/2023, 11:59 PM EST
Start Activity

  • Credits Available

    Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This activity is intended for gastroenterologists, diabetologists & endocrinologists, and primary care physicians.

The goal of this activity is to improve learners’ ability to identify patients who are at risk for developing NASH and implement early treatments to prevent morbidity and mortality.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Relationship of the pathophysiology of NASH and cardiometabolic syndrome
  • Have greater competence related to
    • Identification of patients who with nonalcoholic fatty liver disease (NAFLD) who require early intervention for the prevention of NASH
    • Recommending pharmacotherapy to reduce progression of nonalcoholic NAFLD to NASH


In accordance with the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, all faculty and planning partners must disclose all their financial relationships with ineligible companies held within the past 24 months. 

The AGA Institute implements a mechanism to identify and mitigate all conflicts of interest prior to delivering the educational activity to learners. 


  • Kenneth Cusi, MD

    Professor of Medicine ​
    Division of Endocrinology, Diabetes, and Metabolism ​
    University of Florida ​
    Gainesville, Florida ​


    Kenneth Cusi, MD, has the following relevant financial relationships:
    Consultant or advisor for: 89Bio; Altimmune; Arrowhead; AstraZeneca; Bristol Myers Squibb Company; Lilly; Madrigal; Novo Nordisk; Quest; Sagimet; Sonic Incytes; Terns
    Research funding from: Echosens; Inventiva; Novo Nordisk; Poxel; Labcorp; Zydus


  • Fasiha Kanwal, MD, MSHS, AGAF, FAASLD

    Professor of Medicine ​
    Chief, Section of Gastroenterology
    and Hepatology ​
    Baylor College of Medicine ​
    Houston, Texas


    Fasiha Kanwal, MD, MSHS, AGAF, FAASLD, has no relevant financial relationships.


  • Briana Betz, PhD

    Medical Education Director, Medscape, LLC


    Briana Betz, PhD, has no relevant financial relationships.

Compliance Reviewer

  • Susan L. Smith, MN, PhD

    Associate Director, Accreditation and Compliance, Medscape, LLC


    Susan L. Smith, MN, PhD, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements

Presented through a collaboration between American Gastroenterological Association (AGA) and Medscape Education.


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) by the American Gastroenterological Association (AGA) Institute. 

The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    For Physicians

  • The AGA Institute designates this enduring material for a maximum of 0.5  AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.


Implementing the NASH Clinical Care Pathway

Authors: Kenneth Cusi, MD; Fasiha Kanwal, MD, MSHS, AGAF, FAASLDFaculty and Disclosures

CME Released: 12/28/2022

Valid for credit through: 12/28/2023, 11:59 PM EST


Learning Feedback Questions

Please answer these questions to complement your learning experience.

  • Print